Amphastar Pharmaceuticals

Recent news

• Rating change
  BofA Securities Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Maintains Target Price $30
  Market Newswire · 2026/2/25
• Rating change
  Wells Fargo Maintains Amphastar Pharmaceuticals(AMPH.US) With Buy Rating, Cuts Target Price to $30
  Market Newswire · 2026/2/27
• Rating change
  Needham Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating
  Market Newswire · 2026/7/9
• Rating change
  Analysts Offer Insights on Healthcare Companies: Caris Life Sciences, Inc. (CAI), Amphastar Pharmaceuticals (AMPH) and Amylyx Pharmaceuticals Inc (AMLX)
  TipRanks · 2026/5/8
• Rating change
  Needham Maintains Amphastar Pharmaceuticals(AMPH.US) With Buy Rating, Maintains Target Price $30
  Market Newswire · 2026/4/15
• Rating change
  Needham Downgrades Amphastar Pharmaceuticals(AMPH.US) to Hold Rating
  Market Newswire · 2026/5/8
• Rating change
  BofA Securities Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Cuts Target Price to $28
  Market Newswire · 2026/2/27
• Rating change
  Barclays Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Cuts Target Price to $20
  Market Newswire · 2026/6/4
• Wells Fargo Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Raises Target Price to $20
  Market Newswire · 2026/8/7
• Rating change
  Barclays Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Cuts Target Price to $23
  Market Newswire · 2026/4/8
• Needham Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Announces Target Price $20
  Market Newswire · 2026/8/7
• Rating change
  Needham Maintains Amphastar Pharmaceuticals(AMPH.US) With Buy Rating, Cuts Target Price to $30
  Market Newswire · 2026/2/27
• Rating change
  Needham Maintains Amphastar Pharmaceuticals(AMPH.US) With Buy Rating, Maintains Target Price $34
  Market Newswire · 2026/2/25
• Piper Sandler Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Cuts Target Price to $20
  Market Newswire · 2026/8/7
• Rating change
  Wells Fargo Initiates Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Announces Target Price $19
  Market Newswire · 2026/5/14
• Amphastar Pharmaceuticals (AMPH) Gets a Hold From J.P. Morgan
  TipRanks · 2026/7/23
• Rating change
  Piper Sandler Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Cuts Target Price to $21
  Market Newswire · 2026/5/11
• Rating change
  Analysts Offer Insights on Healthcare Companies: CVRx (CVRX), Ardent Health Partners, Inc. (ARDT) and Amphastar Pharmaceuticals (AMPH)
  TipRanks · 2026/6/3
• Barclays Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Raises Target Price to $23
  Market Newswire · 2026/8/19
• Rating change
  BofA Securities Downgrades Amphastar Pharmaceuticals(AMPH.US) to Sell Rating, Cuts Target Price to $20
  Market Newswire · 2026/6/29

Headlines are aggregated automatically and are not independently verified or edited by our team.